Abstract
Sourcing country specific costing data relating to fertility treatment can be difficult. Costing data is essential to support health care decision makers with economic tools that are aligned to their perspective. This is of particular relevance in fertility, where both treatment pathway and treatment outcome costs can have a greater impact on economic approaches compared to drug acquisition costs. The aim of this study is to source key costing inputs for the in vitro fertilization (IVF) treatment pathway in a Spanish setting.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
